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Glycoprotein G (gG) of equine herpesvirus type 1 (EHV-1), a structural component of virions and secreted from virus-infected cells, was
shown to bind to a variety of different chemokines and as such might be involved in immune modulation. Little is known, however, about its role
in the replication cycle and infection of EHV-1 in vivo. Here we report on the function of gG in context of virus infection in vitro and in vivo. A
gG deletion mutant of pathogenic EHV-1 strain RacL11 (vL11ΔgG) was constructed and analyzed. Deletion of gG had virtually no effect on the
growth properties of vL11ΔgG in cell culture when compared to parental virus or a rescuant virus vL11ΔgGR, respectively, and virus titers and
plaque formation were unaffected in the absence of the glycoprotein. Similarly, in the murine model of EHV-1 infection, no significant differences
in virulence between the gG deletion mutant and RacL11 or vL11ΔgGR were found at high doses of infection. However, infection of mice at
lower doses revealed that the gG deletion mutant was able to replicate to higher titers in lungs of infected mice. Additionally, these mice lost
significantly more weight than those infected with RacL11 and a more pronounced inflammatory response in lungs was observed. Therefore we
concluded that deletion of gG in EHV-1 seems to lead to an exacerbation of respiratory disease in the mouse.
© 2006 Elsevier Inc. All rights reserved.Keywords: Chemokine receptor; Glycoprotein; Herpesvirus; Pathogenesis; MouseIntroduction
Equine herpesvirus type 1 (EHV-1), a member of the Vari-
cellovirus genus within the subfamily Alphaherpesvirinae, is an
important pathogen of horses worldwide. Infection with EHV-1
may result in rhinopneumonitis, abortion in pregnant mares, and
fatal myeloencephalopathy (Patel and Heldens, 2005). EHV-1
glycoproteins are involved in virion attachment, penetration, cell-
to-cell fusion and egress. In addition, many of them have been
shown to play major roles in viral pathogenesis in vivo (reviewed
in Osterrieder et al., 1999). Because of their location in the viral
envelope and on the surface of infected cells, glycoproteins are
also prime targets of the host's immune response. To survive the
hostile environment imposed by host immunity, many viruses
interact with crucial immunomodulatory molecules and interfere⁎ Corresponding author. Fax: +1 607 253 3384.
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doi:10.1016/j.virol.2006.12.008with their activity (reviewed in Lybarger et al., 2005; Hewitt,
2003). Mimicry of host chemokines or chemokine receptors to
modulate chemokine activity is a common strategy for generating
a favorable environment for virus replication that is employed by
many pox- and herpesviruses (Boomker et al., 2005). Alter-
natively, through secretion of virus-encoded chemokine-binding
proteins (vCKBPs), poxviruses but also the murine gammaher-
pesvirus 68 are able to prevent chemokine binding to chemokine
receptors or to proteoglycans (Graham et al., 1997; Lalani and
McFadden, 1997; Parry et al., 2000). The recent finding that
glycoprotein G (gG) isoforms from several alphaherpesviruses
are able to bind a broad spectrum of chemokines and function as a
secreted vCKBP may indicate an important role of gG in the
process of viral immune evasion in alphaherpesvirus infection
(Bryant et al., 2003).
Glycoprotein G homologues have been identified in most but
not all alphaherpesviruses (McGeoch, 1990; Schwyzer and
Ackermann, 1996). Although gG has been shown to be dis-
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virus-1 (HSV-1) (Balan et al., 1994), bovine herpesvirus-1
(BHV-1) (Nakamichi et al., 2000; Trapp et al., 2003), and
pseudorabies virus (PRV) (Mettenleiter et al., 1990), the exact
role of gG in herpesvirus infection is not fully understood. In
HSV-1, a virus lacking gG was impaired with respect to
infection of apical surfaces of polarized cells in cell culture, but
showed very moderate attenuation in the mouse eye model
(Balan et al., 1994; Tran et al., 2000). BHV-1 gG appears to be
involved in cell-to-cell spread of the virus by maintaining
intracellular junctions in infected cells (Nakamichi et al., 2000,
2002; Trapp et al., 2003). A role of BHV-1 gG in prevention of
apoptosis has also been reported (Nakamichi et al., 2001). A
significant reduction in virulence and protection against disease
by challenge infection was described, although clinical signs of
BHV-1 infection were observed in calves infected with a gG-
negative mutant (Kaashoek et al., 1998). In the case of
infectious laryngotracheitis virus (ILTV), deletion of gG results
in attenuation of the virus together with increased inflammatory
infiltration at the site of infection in birds (Devlin et al., 2006).
The gG homologue of EHV-1, encoded by gene 70, shares
some features with gGs of other herpesviruses but has
interesting and unique properties as well. While most
glycoproteins are under transcriptional control of late promo-
ters, expression of gG is controlled by an early promoter (Colle
and O'Callaghan, 1995). A second unusual property of gG is its
secretion from infected cells (Drummer et al., 1998). In addition
to the secreted form of EHV-1 gG, virion-associated forms were
also found (Drummer et al., 1998). Recently it was shown that
the secreted and membrane-anchored forms of EHV-1 gG
function as vCKBPs that bind a broad range of chemokines in a
species-independent fashion. Chemokine binding occurs with
high affinity and it was suspected that their activity is blocked
by preventing interaction with specific receptors (Bryant et al.,
2003). The data suggested that the in vivo role of gG is to
interact with the hosts' chemokine network and indicated that
gG might be involved in EHV-1 immune evasion.
Here we report on the construction and analysis of virulent
EHV-1 strain RacL11 deleted in gene 70 (gG). We show that gG
is nonessential for virus growth in vitro and in vivo and that
growth of gG-negative viruses in cultured cells is virtually
indistinguishable from that of parental or rescuant viruses. In
mice infected with the gG-negative virus, severe signs of
respiratory disease as reflected by a massive infiltration of
immune cells, weight loss, and increased virus titers in lungs
were observed especially when lower virus titers were used for
infection [1×103 and 1×104 plaque-forming units (PFU) per
mouse]. In contrast, mice infected with wild-type virus showed
less severe signs of respiratory disease, virus replication and
weight loss using lower doses of infection.
Results
Deletion of glycoprotein G in EHV-1
To construct a gG deletion mutant of virulent EHV-1 strain
RacL11, the majority of the gG open reading frame (gene 70)was replaced with a prokaryotic selection marker, the aphAI
gene conferring kanamycin resistance, by Red mutagenesis in
Escherichia coli in the previously generated pL11 BAC clone
(Rudolph and Osterrieder, 2002; Rudolph et al., 2002a). The
resulting gene 70-negative BAC mutant was termed pL11ΔgG
(Fig. 1). The correct insertion of the aphAI gene and deletion of
gene 70 was confirmed by restriction fragment length
polymorphism (RFLP) analysis, PCR and nucleotide sequence
analyses (Fig. 1). Mutant pL11ΔgG BAC DNA, isolated from
E. coli, was transfected into RK13 cells to reconstitute the gG
deletion mutant designated vL11Δgp2/gG, which also lacks
gene 71 encoding gp2 (Table 1) (Rudolph et al., 2002a). To
restore expression of gp2 encoded by gene 71 or gp2 and gG,
RK13 cells were co-transfected with pL11ΔgG DNA and
plasmid p71L11 or plasmid pE6.6, respectively (Fig. 1).
Homologous recombination of plasmid p71L11 and pL11ΔgG
DNA resulted in reinsertion of the gp2-encoding sequences and
therefore in reconstitution of a gG-negative mutant virus that
was termed vL11ΔgG-A. The restoration of expression of both
gp2 and gG in the gG rescuant virus vL11ΔgGR-Awas achieved
by co-transfection of RK13 cells with pL11ΔgG DNA and
plasmid pE6.6, followed by plaque purification.
For comparative purposes, a second set of both a gG-
negative virus and a gG revertant virus was generated. Viral
(and not BAC) DNA, which had been isolated from vL11Δgp2/
gG-infected cells, was used for this set of mutants. As described
above for the use of BAC DNA, vL11Δgp2/gG DNA was co-
transfected with either of the plasmids and virus progeny was
purified to homogeneity.
Characterization of mutant viruses
The genotypes of all generated and tested virus mutants were
confirmed by restriction enzyme analyses using BamHI and
HindIII (data not shown), nucleotide sequencing, and PCR
using gG-1 and gG-2 (Table 1 and Fig. 1E). The presence of the
gG-encoding gene 70 resulting in a PCR product of 1.2 kbp in
size was detected in cells infected with RacL11, vL11Δgp2,
vL11ΔgGR-A, and vL11ΔgGR-B, while the aphAI gene
inserted into gene 70 resulted in a product of 1.5 kbp in size
in cells infected with vL11Δgp2/gG, vL11ΔgG-A and
vL11ΔgG-B (Fig. 1E).
Western blot analysis of infected cell lysates and purified
virions was employed to detect the various forms of gG with the
anti-gG antibody. Specific reactivity was obtained in protein
lysates obtained from the parental and gG rescuant viruses
(Drummer et al., 1998), but not in those from gG null mutants
(Fig. 2A). Indirect immunofluorescence using anti-gp2 Mab
confirmed restoration of gp2 expression through reinsertion of
gene 71 for all viruses but the vL11Δgp2/gG virus, which was
expected because it was devoid of gene 71 (Fig. 2B). From the
results of the RFLP, PCR, sequencing,Western blot, and IFA, we
concluded that the gp2-encoding sequence or both the gG- and
gp2-encoding sequenceswere absent from or correctly reinserted
into the generated virus mutants as intended and that no spurious
mutations or rearrangements elsewhere in the genomes had
occurred (Table 1).
Fig. 1. Generation of mutant virus vL11ΔgG/gp2 and plasmids pE6.6 and p71L11. (A) Shown is the overall genome organization of the recombinant EHV-1 BAC
pL11ΔgG/gp2 consisting of a unique-long (UL) and a unique-short (US) segment, which is bracketed by inverted internal repeat (IR) and terminal repeat (TR)
sequences, and the BamHI map. (B) Depiction of the unique-short segment of pL11ΔgG/gp2 from gene 74 (encoding gI) through gene 68 (US2 homologue) with
arrowheads indicating the transcriptional directions of the various genes. The aphAI gene was inserted in lieu of gene 70 (encoding gG) that is located upstream of the
mini-F vector sequences derived from plasmid pHA2. (C, D) Organization of the same unique-short segment depicted in (B) of wild-type RacL11 virus. Sequences of
RacL11, which are contained in plasmids p71L11 and pE6.6, were used for the generation of the gG-negative and the gG-rescuant viruses, respectively (Table 1).
Scales and restriction enzyme site (B, BamHI; S, SphI; E, EcoRI) are given. (E) PCR analysis of the generated recombinant viruses using primers gG-1 and gG-2.
Intact gene 70 yields a fragment of 1.2 kbp, whereas virus DNA containing the aphAI gene results in a fragment of 1.5 kbp. The molecular size marker is the 1-kb
ladder (Invitrogen).
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gG gene of various strains of PRV have shown varying
phenotypes caused by reduced expression levels of the product
of the US3 homologous gene encoding the unique-short protein
kinase, which is translated directly upstream from gene 70, andnot by the absence of gG (Demmin et al., 2001). In addition,
transcriptional analyses of the unique-short segment of the
genome revealed that the EHV-1 US3 orthologue shares the 3′
end with gene 70 encoding gG (Colle and O'Callaghan, 1995).
Therefore, to exclude an impairment of US3 protein (pUS3)
Table 1
Viruses generated and used in this study
Virus designation Mode of virus generation Genotype
RacL11 NAa Parental virus
RacL11Δgp2 Transfection of BAC clone
pRacL11
gp2-negative
vL11Δgp2/gGb Transfection of
pL11ΔgG/gp2 (Fig. 1)
gG- and
gp2-negative
vL11ΔgG-Ab Cotransfection with
vL11Δgp2/gG DNA and
p71L11 (Fig. 1)
gG-negative,
gp2 restored
vL11ΔgGR-Ab Cotransfection with
vL11Δgp2/gG DNA and
pUC-E6.6 (Fig. 1)
gG and gp2
restored
vL11ΔgG-Bb Cotransfection with pL11ΔgG
DNA and p71L11
gG-negative,
gp2 restored
vL11ΔgGR-Bb Cotransfection with pL11ΔgG
DNA and pUC-E6.6
gG and gp2
restored
a NA, not applicable.
b Two independent recombinant viruses were purified to homogeneity and
their growth properties in vitro compared. No differences between the two
isolates could be found and thus data for only one of the recombinant viruses
each are presented.
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Western blot analyses were performed on lysates of cells
infected with the various viruses. Expression levels of pUS3 in
mutant viruses were compared with that of parental RacL11
virus and found to be very similar (Fig. 2C). Although
interference with gene 71 expression through insertion of the
aphAI sequence was not expected, Western blot analyses
were performed, which demonstrated no difference in expres-
sion levels of gp2 in vL11ΔgG-A and vL11ΔgG-B, respec-
tively (data not shown). From the results we concluded that
insertion of the aphAI gene in the gG-negative viruses
vL11ΔgG-A and vL11ΔgG-B did not have detrimental effects
on the expression of neighboring genes of the unique-short
segment.
In vitro growth properties of gG-negative mutants
In a series of experiments, the in vitro growth properties of
the generated gG-negative viruses in RK13 cells were analyzed.
To assess a possible contribution of gG to the cell-to-cell spread
of EHV-1, plaque areas of vL11ΔgG-A and vL11ΔgG-B were
quantified and compared to those of parental RacL11 and gG
rescuant viruses. The results from three independent experi-
ments are summarized in Fig. 3A, and revealed no significant
differences in virus plaque sizes between wild-type, gG-
negative, and gG revertant viruses. Only in the case of the
gp2/gG double-negative virus, vL11Δgp2/gG, a slight reduc-
tion in plaque size of approximately 5% was observed when
compared to wild-type virus, which was completely restored
after reinsertion of gene 71 encoding gp2. This observation was
consistent with the previously described impairment of plaque
formation in the absence of gp2 (von Einem et al., 2004) and
suggested that the defect in cell-to-cell spread of vL11Δgp2/gG
was caused by the lack of gp2 only. From these results we
concluded that the deletion of gG in EHV-1 – in contrast to thesituation in other Alphaherpesvirinae – has no influence on
direct cell-to-cell spread of infectivity.
Virus titers on RK13 cells using the various recombinant
viruses were also determined. All tested viruses grew to similar
virus titers, with no differences in end-point virus titers between
the gG deletion mutants vL11ΔgG-A and vL11ΔgG-B,
parental RacL11, and the respective gG rescuant viruses (Fig.
3B). The approximately 10-fold reduction of vL11Δgp2/gG
virus titers compared to those of RacL11 was identical with that
described for a gp2-deletion mutant of RacL11. We therefore
concluded that the reduction in titer of the double deletion
mutant is caused by the absence of gp2 only (Rudolph et al.,
2002a). Taken together, these data strongly suggested that gG is
completely dispensable for growth of EHV-1 in cultured cells.
Pathogenesis of EHV-1 infection in a murine infection model is
not affected by absence of gG at high doses of infection
The ability of EHV-1 gG to bind chemokines and to interfere
with their activity by blocking chemokine binding to appropriate
receptors might affect the pathogenicity of EHV-1. Therefore, the
impact of gG on the pathogenicity of EHV-1 was assessed in a
murine model of EHV-1 infection. First, high doses of infection of
1×105 PFU of the gG-negative viruses vL11ΔgG-A or vL11ΔgG-
B, the gG rescuant viruses vL11ΔgGR-A or vL11ΔgGR-B, or
parental RacL11 virus were used to infect mice intranasally (Table
1). Following infection, animals were observed daily for clinical
signs of virus infection, such as respiratory distress, crouching,
huddling, and ruffled fur.Mice infectedwith RacL11, vL11ΔgGR-
A or vL11ΔgGR-B showed clinical signs typical for the infection
as early as day 1 post-infection (p.i.). Similar clinical signs were
also observed, however, in mice infected with the gG-negative
viruses. Signs indicative of EHV-1 respiratory disease were
observed up to 7 days p.i. in all groups of mice, except mock-
infected animals. Due to the severity of the infection, two mice
infected with RacL11 and one mouse infected with vL11ΔgGR-B
died on days 3 and 4 p.i., respectively.
All mice were weighed immediately prior to infection and
daily thereafter to monitor body weight loss. Consistent with the
observations regarding clinical expression of EHV-1 infection
in mice of the various groups, no statistically significant
difference between individual groups in mean values or the
course of body weight loss could be observed at the high dose of
infection. As shown in Fig. 4, mice infected with vL11ΔgG-A
or vL11ΔgG-B began losing body weight on day 1 p.i.,
continued losing body weight up to day 5, and reached pre-
infection weights by the end of the observation period. The
body weight curves were almost identical to those of parental
RacL11 and the rescuant viruses.
Absence of gG exacerbates respiratory disease at lower doses
of infection
One possible explanation for the very similar pathogenicity
of the gG-negative, wild-type and gG rescuant virus was
masking of subtle effects by the previously described role of the
unique glycoprotein gp2 in the inflammatory response upon
Fig. 2. (A) Purified virions (V) and cell lysates (C) of the indicated viruses were separated by SDS–12% PAGE, transferred to a nitrocellulose membrane, and
incubated with either anti-gG rabbit antiserum (1:1000) or control anti-ETIF Mab L3ab (1:2000). The various forms of gG [gGS—secreted gG, gGVL and gGVS—
virion-associated gG's (Drummer et al., 1998)] are indicated by arrows. The sizes of the PageRuler Prestained Protein Ladder (Fermentas) are given in thousands. (B)
Indirect immunofluorescence analysis of RK13 cells infected with the various recombinant viruses detecting gp2 expression from gene 71 located downstream of the
aphAI insertion into gene 70 of RacL11. Cells were fixed with acetone on day 2 after infection, incubated with anti-gp2Mab 3B12 and visualized using anti mouse IgG
Alexa Fluor 488 antibody (Molecular Probes). (C) Western blot analysis detecting expression of pUS3 from gene 69 located upstream of the aphAI insertion in the
various recombinant viruses 18 h p.i. Identical protein concentration were loaded and separated by SDS–12% PAGE under reducing conditions. Separated proteins
were transferred to a nitrocellulose membrane and incubated with anti-pUS3 rabbit antiserum (1:1.000 dilution). The sizes of the used prestained molecular weight
marker (Precision Plus Protein; Bio-Rad) are given in thousands.
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infection (Smith et al., 2005). Therefore, the impact of absence
of EHV-1 gG on pathogenicity was assessed by using lower
virus doses for infection. In a separate animal experiment,
groups of ten mice each were infected with 1×103, or 1×104, or
1×105 PFU per mouse, and virus titers were determined in
lungs of infected mice on days 2 and 4 p.i. Infected mice were
also monitored for clinical signs of infection and for body
weight loss throughout the experiment period.
On day 2 p.i. virus titers in the lungs of mice infected with
the gG-negative mutant were almost identical to those of the
parental virus, irrespective of the dose of infection (Fig. 5).
Virus titers in lungs of more than 1×106 PFU for the gG-
negative virus as well as RacL11 and rescuant virus indicatedthat all viruses replicated with virtually identical kinetics
during the first 2 days of infection, irrespective of the
presence or absence of gG. In contrast, on day 4 p.i., virus
titers of the gG-negative virus were significantly higher when
compared to those of wild-type virus and rescuant virus at the
lower doses of infection (1×103 and 1×104 PFU) (Fig. 5).
As observed earlier, no significant differences in lung titers
were detected between the three different viruses when
infection was performed with 1×105 PFU per mouse (data
not shown). Additionally, declining virus titers at day 4 for all
tested viruses and infection doses indicated beginning
clearance of the virus infection from the lung, but we noticed
that the virus titers in the lungs on day 4 p.i. were dependent
on the dose of infection.
Fig. 3. Plaque sizes (A) and end-point titers (B) of RacL11 and the recombinant
viruses (Table 1). Plaque areas of each virus were determined after 3 days p.i.
and compared to the plaque sizes of RacL11 which was set at 100%. Shown are
means of plaque areas from three independent experiments. End-point titers
(36 h p.i.) of each recombinant virus were determined by titrations of entire
infected-cell suspensions on RK13 cells.
Fig. 4. Development of mean body weights. Mice in groups of six were infected
intranasally with 1×105 PFU of the indicated virus or mock. Mean body weights
were determined on the day of infection (day 1) and each subsequent day
through day 12. Each data point represents the mean of the body weight for the
indicated group at the indicated time point. The mean of the body weight on the
day of infection was set at 100%. Standard deviations (SD values) ranged from
0.8% to 17.2%. Maximal SD values and the day of maximal SD for the
individual preparations are indicated in brackets.
156 J. von Einem et al. / Virology 362 (2007) 151–162When body weight loss after infection was analyzed, no
significant difference could be observed in mice infected with
doses of 1×105 PFU, which is consistent with the experiments
described earlier. In contrast, mice infected with gG-negative
EHV-1 exhibited higher body weight losses than those infected
with RacL11 at doses of 1×103 and 1×104 PFU, which
corroborated with the findings of higher virus titers in the lungs
of infected animals (data not shown).
Body weight loss caused by EHV-1 infection is strongly
associated with an inflammatory response and a subsequent
inflammatory infiltration of infected lungs in mice (Smith et al.,
2005). To examine the inflammatory response, we removed
lungs from mice infected with 1×103 and 1×104 PFU, res-
pectively, of RacL11 and gG-negative virus at day 4, when
clinical signs were most severe, and examined the inflamma-
tory infiltration in histological sections. Lungs of mice infected
with gG-negative virus exhibited extensive perivascular and
peribronchial cuffing as well as interstitial inflammatory infil-
tration. In contrast, significantly less inflammatory responses
were observed in mice infected with parental RacL11 virus
(Fig. 6). It should be noted that no difference in theinflammatory response in lungs of mice infected with
RacL11, the gG-negative viruses or the rescuant viruses could
be observed in the experiments described earlier using doses of
1×105 PFU (data not shown). From the results of the in vivo
experiments we concluded that deletion of gG apparently allows
the virus to replicate more efficiently in lungs of infected mice,
especially when lower doses of infection are used, which
ultimately leads to a more pronounced weight loss and clinical
symptoms of infection.
Discussion
In the present study, experiments were conducted to assess
the role of gG for EHV-1 replication in cultured cells and –
more importantly – with respect to pathogenesis in a murine
model of EHV-1 infection. The salient findings reported here
are that absence of gG had no effect on growth properties of
EHV-1 in vitro. Importantly, deletion of gG resulted in increased
respiratory pathogenicity of EHV-1 in mice as reflected by
higher virus titers in lungs of infected mice when compared to
parental or rescuant virus. These effects were only evident at
lower doses of infection. In addition, an increased inflammatory
cell infiltration in the lung was detected in mice infected with
gG-negative virus. Therefore a modulating role of gG in
pathogenesis of EHV-1 in the murine infection model could be
demonstrated.
EHV-1 encodes for at least 12 envelope (glyco)proteins of
which some, e.g. gB, gE, gI, gM, and gp2, have been identified
as virulence factors that significantly contribute to EHV-1
pathogenicity in model systems or the natural host (Frampton
Fig. 5. Virus titers in lungs after infection with lower virus doses. Each mouse
was infected with 1×103 (A) or 1×104 (B) PFU of RacL11 (▪), vL11ΔgG-A
(○), and vL11ΔgGR-A (▴). Virus titers in lungs were determined from five
mice of each group on days 2 and 4 p.i. Titers of individual mice (data points) as
well as means (horizontal bars) are given; asterisks indicate statistically
significant differences (P<0.05) between mice inoculated with RacL11/
vL11ΔgGR-A on the one hand and vL11ΔgG-A on the other hand.
157J. von Einem et al. / Virology 362 (2007) 151–162et al., 2002; Neubauer et al., 1997; Osterrieder et al., 2001;
Smith et al., 2005; von Einem et al., 2004). The genes encoding
four of the glycoproteins are located within the unique-short
segment of the genome and conserved among most alphaher-
pesviruses. Sequence analysis of these genes have suggested
that gD, gG, gE, and gI have evolved by gene duplication
(McGeoch, 1990; Schwyzer and Ackermann, 1996). Important
functions for the growth of EHV-1 in vitro and in vivo have
been assigned for gD, gE, and gI, while no clear or consistent
function could be attributed to gG orthologues of the virus
subfamily. The results of our study demonstrated that gG doesnot play a major role for EHV-1 replication in cell culture but is
involved in the pathogenesis of EHV-1 in mice. Unlike most
other glycoproteins, gG is known to be secreted, a characteristic
common to gG homologues from other alphaherpesviruses,
with the notable exception of HSV-1 gG. In addition to the
secreted form of gG released from EHV-1-infected cells, two
membrane-bound forms of gG that are incorporated into virions
have been identified (Drummer et al., 1998), while it remains to
be determined whether gG homologues from other alphaher-
pesviruses also encode membrane-bound forms. Despite
membrane association of gG, our data suggest that gG is not
involved in cell-to-cell spread or egress of EHV-1 in cell
culture, which is consistent with recently published results
(Huang et al., 2005). Our conclusions were drawn from
experiments using gG-negative mutants of virulent EHV-1
strain RacL11, which showed that direct cell-to-cell spread and
virus egress were not significantly different from wild-type or
revertant viruses. Our findings are also similar to those obtained
from studies of gG in HSV-1, BHV-1 and PRV showing that gG
is dispensable for virus growth in cell culture (Balan et al.,
1994; Demmin et al., 2001; Nakamichi et al., 2000; Weber et al.,
1987). While HSV-1 gG might play an important role in the
infection of polarized cells through apical surfaces (Tran et al.,
2000), investigations on the function of gG in BHV-1 showed
its contribution to cell-to-cell spread may be in maintaining tight
intercellular contacts, but no impairment was observed with
regard to single-step growth kinetics of independently generated
gG-negative mutants (Nakamichi et al., 2000, 2002; Trapp et
al., 2003). It should be noted that some functions ascribed to gG
from these studies may need to be reassessed in the light of
evidence that expression levels of the unique-short protein
kinase pUS3, which is located immediately upstream of gG, are
decreased as a consequence of the deletion of gG in PRV
(Demmin et al., 2001). The negative effects exerted by an
impairment of protein kinase expression were ruled out by
demonstrating unaltered expression levels of pUS3 in our gG-
mutants (Fig. 2C).
The recent finding that EHV-1 gG functions as a broad range
vCKBP (Bryant et al., 2003), in conjunction with its properties
of being expressed at early stages of infection (Colle and
O'Callaghan, 1995) and secreted (Drummer et al., 1998), has
suggested a possibly important function of gG in EHV-1
pathogenesis. The virulence of the gG-negative mutants was
tested in the mouse model of EHV-1 respiratory disease. Typical
for infection of mice with pathogenic EHV-1 is a dramatic loss
of up to 25–30% of the body weight within days of infection,
and clinical signs of infection include crouching, ruffled fur, and
cuddling. In our experiments, no significant difference in the
course of infection or in the severity of the disease was observed
in mice infected with gG-negative mutants compared to parental
strain RacL11 and gG revertant viruses using a high infection
dose of 1×105 PFU per mouse. However, in experiments where
lower doses were used (1×104 or 1×103 PFU per animal), the
gG-negative mutants presented with higher titers in the lung of
infected mice, and infection with those mutants resulted in
severe clinical signs, stronger inflammatory infiltration in the
lung, and more dramatic weight loss when compared to parental
Fig. 6. Histological sections of lungs of mice infected with gG-negative or wild-type viruses. Mice were infected intranasally with the indicated doses of RacL11 or the
gG-negative vL11ΔgG-Avirus. On day 4 p.i., mice were sacrificed and lungs were infused with OCTand removed. Lung tissue was mounted in tissue molds, covered
in OCT, sectioned with a cryostat, fixed, and stained with hematoxylin and eosin. Slides were inspected by light microscopy and photographed at 10× magnification.
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the lung of mice infected with the gG-negative virus is a more
robust replication. Alternatively, less efficient clearance of the
virus, as supported by previous (Huang et al., 2005) and by our
data showing absolutely no difference in virus growth of such a
mutant compared to wild-type virus in cell culture, may also
contribute to the detection of higher virus loads and might
explain the much more pronounced inflammation. Discovery of
the significant increase in pathogenicity of the gG-negative
virus compared to parental virus led us to conclude that gG can
function in binding mouse cytokines in a biologically relevant
fashion and as such is able to modulate the host's immune
response to infection. Interestingly, absence of gG did not result
in a decrease but an increase in total virus lung titers indicating
that herpesvirus–host interaction is a delicately fine-tuned
relationship that is aimed at finding an equilibrium that would
allow virus replication without doing too much harm to the host.
Although intensive characterization of herpesvirus encoded
vCKBPs in vitro, the in vivo effects of viral interference with
the chemokine network on host immunity are largely unknown.
The expression of vCKBP by poxviruses appears to inhibit the
recruitment of inflammatory cells into virus-infected tissues.
Although increased inflammation at the site of primary
infection was observed with poxviruses unable to express
vCKBPs, no evidence of attenuation was observed in mice
infected with mutant viruses when compared to those infected
with wild-type virus in those models (reviewed in Lalani et al.,
2000). The consequence of infection with murine gammaher-
pesvirus-68 (MHV-68) lacking the M3 gene, which encodes a
broad-spectrum, secreted vCKBP, is not completely understood
as well. In studies using a mutant virus in which the M3 ORF
was disrupted, a role for this protein in establishment of latencywas proposed (Bridgeman et al., 2001). A subsequent study
found a reduction in virulence of a M3 mutant after intra-
cerebral inoculation into mice and alteration of the expression
of several CC chemokines compared to wild-type virus infec-
tion, which resulted in a shift of the inflammatory response
dominated by lymphocytes and monocytes to one that was
characterized by the recruitment of neutrophils (van Berkel et
al., 2002). Recently, attenuation and increased inflammatory
infiltration at the site of infection has been observed in birds
infected with a gG-deficient mutant of infectious laryngotra-
cheitis virus (ILTV) (Devlin et al., 2006). Our data on EHV-1
gG obtained from the animal experiments suggest a different,
novel function for a vCKBP, which is apparently able to miti-
gate infection and thereby clinical outcome at least in the
murine infection model.
In the mouse model, the inflammatory response to the virus
infection seems to play an important role for the outcome of the
infection, i.e. for the severity of clinical signs and the
consequential weight loss. These findings are supported by
our data from dose–response experiments in which infection
with a gG-negative virus elicited a strong inflammatory
infiltration in the lung and substantial body weight losses of
infected mice. Previous studies comparing pathogenic and
attenuated EHV-1 strains such as RacL11 and KyA have
demonstrated that the increased expression of proinflammatory
cytokines such as MIP-1α, MIP-1β, MIP-2 and TNF-α and the
resulting inflammatory infiltration plays a major role in the
severe respiratory disease elicited by infection with RacL11
(Smith et al., 2000). The difference in the cytokine pattern of
RacL11 compared to KyA correlates with the expression of the
unique glycoprotein 2 (gp2), which harbors a major in-frame
deletion in strain KyA (Colle et al., 1992; Smith et al., 2005).
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explanation why mice infected with high doses of 1×105 PFU
of the gG-negative mutant show no difference to mice infected
with parental virus RacL11 and why little if any differences
were observed between parental and gG-negative viruses in this
assay (data not shown). Given the role of gG as a vCKBP and
the importance of the expression of proinflammatory factors in
EHV-1 respiratory disease, it was compelling to speculate that
deletion of gG could influence the severity of respiratory
inflammatory disease elicited by EHV-1. Our data clearly show
that this was only true for infections using lower virus doses.
Again, the prominent effect of gp2 onto the course of
respiratory disease and the attraction of immune cells might
be the explanation why mice infected with high doses of
1×105 PFU of the gG-negative mutant show no difference to
mice infected with parental virus RacL11.
Taken together, our findings reported here do not reveal an
obvious function of gG in the replication cycle of EHV-1 in
cell culture but clearly demonstrate involvement of gG in
EHV-1 pathogenicity in the murine model. However, the exact
mechanisms of action of gG on murine and equine cytokines
remain to be determined and are currently under investigation,
as is the behavior of the gG-negative mutants in the natural
host.
Materials and methods
Plasmids
The construction of plasmid p71L11 used for reinsertion of
the gp2-encoding sequence of EHV-1 strain RacL11 is
described elsewhere (von Einem et al., 2004). The 6.6-kbp
EcoRI genomic DNA fragment of strain RacL11 comprising the
coding sequences for gG and gp2 was cloned into cloning
vector pUC18 (Fermentas) resulting in plasmid pE6.6 (Fig. 1).
Mutagenesis of pRacL11
The pRacL11 bacterial artificial chromosome (BAC) clone
was generated previously by replacing gene 71 encoding gp2
with mini-F vector sequences (Rudolph et al., 2002a). The gG-
null mutant of pRacL11 was generated using Red mutagenesis
where the majority of gene 70 encoding gG (comprising nt
127872 to nt 128891, according to the sequenced EHV-1 strain
Ab4) was replaced with an antibiotic resistance gene, but
leaving a potentially functional polyA site of gene 69 intact
(Telford et al., 1992) (Fig. 1). Mutagenesis of pRacL11 DNA
was performed using E. coli EL250 cells (kindly provided by
Dr. Neil G. Copeland), which express the heat-inducible λ
phage recombination enzymes Exo, Beta, and Gam (Lee et al.,
2001). EL250 cells carrying pRacL11 were grown at 32 °C in
Luria–Bertani (LB) medium with chloramphenicol (30 μg/ml)
to an OD600 of 0.5, heated at 42 °C for 15 min, washed three
times with 10% glycerol to render them electrocompetent, and
concentrated 100-fold (Muyrers et al., 1999). About 50 μl of
competent cells were electroporated (1.25 kV/cm, 200 Ω,
25 μF) with 100 ng of a PCR product of the aminoglycosidephosphotransferase gene (aphAI) derived from pKD13 (Dat-
senko and Wanner, 2000). The primers gGdel-for (5′-ATATTT-
GAGCCCCCAACAATTGCGATTAAAGCTGAATC-
CAAGGGTTGTGAGTGTAGGCTGGACTGCTTC-3′) and
gGdel-rev (5′-ATTTGAAACTTTTATTTGACAGGTGT-
TAAGCAACGTACTCAAGTCGCTGGATTCCGGG-
GATCCGTCGACC-3′) used for the PCR reaction contained
20 nucleotides each of aphAI-specific sequences (bold) and 50
nucleotides of EHV-1-specific sequences to allow for homo-
logous recombination with viral sequences and resulting in the
deletion of gene 70 sequences. After electroporation, cells were
incubated for 1 h at 32 °C in SOC (Sambrook et al., 1989) and
plated onto LB agar containing kanamycin (50 μg/ml) and
chloramphenicol (30 μg/ml). Colonies were grown in liquid LB
with both antibiotics, and BAC DNAwas isolated by a standard
alkaline lysis protocol (Sambrook et al., 1989) or by column
chromatography (Qiagen Plasmid MAXI Kit) according to the
manufacturer's protocol.
DNA analysis
BAC or viral DNA isolated from pro- or eukaryotic cells was
cleaved with appropriate restriction enzymes and separated on
0.8% agarose gels. Additionally, BAC and viral DNA were an-
alyzed by PCR using primers gG-1 (5′-ATGTTGACTGTCTTA-
GCAGC-3′) and gG-2 (5′-TTAAGCAACGTACTCAAGTC-3′)
to verify presence or absence of gene 70.
Viruses and cells
EHV-1 wild-type strain RacL11 (Hubert et al., 1996) and
mutant viruses were grown on rabbit kidney cells (RK13) at
37 °C under a 5% CO2 atmosphere. Cells were maintained in
minimal essential medium (MEM) supplemented with 10%
fetal bovine serum (FBS). Virus was reconstituted after
transfection of 1 to 5 μg of recombinant BAC DNA into
RK13 cells using the calcium phosphate precipitation method
(Rudolph et al., 2002a). To restore gene 71 and/or gene 70
expression, which resulted in either single gG-negative or gp2-
gG revertant viruses (Table 1), 1 μg of plasmid p71L11 or pE6.6
was co-transfected with 5 μg BAC DNA or viral DNA,
respectively. At days 3 to 5 after co-transfection, supernatants
were harvested and transferred to plates in which fresh RK13
cells were seeded, and recombinant non-fluorescing virus
plaques were picked and purified to homogeneity by two
rounds of plaque purification (Rudolph and Osterrieder, 2002).
At least two independent recombinant viruses were isolated
from each of the co-transfections and their growth properties in
vitro were compared. Because no differences between the
individual viruses resulting from one co-transfection were
observed, results for only one of the recombinant viruses are
described (Table 1).
Antibodies
To detect EHV-1 gp2, we used monoclonal antibody (Mab)
3B12, which recognizes full-length gp2 (Meyer and Hubert,
160 J. von Einem et al. / Virology 362 (2007) 151–1621988; Rudolph and Osterrieder, 2002). The anti-gG polyclonal
antibody recognizing the variable region of gG was kindly
provided by Michael J. Studdert and described previously
(Huang et al., 2005). Mab L3ab directed against ETIF was used
as a control antibody in Western blot analyses (Lewis et al.,
1997). For detection of the EHV-1 gene 69 (US3) gene product
(US3p), a monospecific polyclonal rabbit antisera was used
exactly as described earlier (Colle and O'Callaghan, 1996).
Mab E2 directed against EHV-1 gM was kindly provided by
Lindsey Day and Richard Killington, University of Leeds,
Leeds, United Kingdom (Day, 1999; Seyboldt et al., 2000).
Virus titers and plaque area determinations
Titers of the various viruses were determined by infecting
1×105 RK13 cells at a multiplicity of infection (m.o.i.) of 3
exactly as described previously for single step growth kinetics
(Rudolph et al., 2002b). Infected cells were harvested at the
indicated times post-infection (p.i.), and total virus titers were
determined by plating 10-fold dilutions on RK13 cells after a
freeze and thaw cycle. Plaque areas were measured after plating
of the viruses on RK13 cells and 3 days of incubation at 37 °C
under a 0.6% methylcellulose overlay (Rudolph et al., 2002b).
Cells were fixed with 90% acetone and stained by indirect
immunofluorescence using anti-gM MAb E2. Infected cells
were visualized using Alexa Fluor 488 goat anti-mouse IgG
(Molecular Probes) and examined under a fluorescent micro-
scope (Zeiss Axiovert 25). For each virus, plaque areas of at
least 50 plaques for each experiment were determined in
triplicate using the ImageJ 1.28 software that is freely available
from the National Institutes of Mental Health webpage (http://
rsb.info.nih.gov/ij/docs/intro.html). Virus titers and plaque
areas were analyzed by performing an analysis of variance
(ANOVA), followed by multiple comparisons of the groups.
Therefore, p-values were adjusted according to Bonferroni as
described previously (Osterrieder et al., 1996). The SAS v8.2
software (SAS Inst. Cary, NC) was used for statistical
calculations.
Western blotting
For Western blot analyses, cells were infected at an m.o.i. of
2 with the various viruses, and cell lysates were prepared at 18 h
after infection. Lysates of infected cells were adjusted to equal
protein concentrations after determination of protein contents of
samples using the BCA kit (Pierce) (Osterrieder et al., 1997).
Samples were separated by sodium dodecyl sulfate (SDS)
12%–polyacrylamide gel electrophoresis (PAGE), and trans-
ferred to nitrocellulose membranes (BioRad) by the semi-dry
method (Kyhse-Andersen, 1984). Free binding sites on the
sheets were blocked by addition of 5% skim milk in phosphate-
buffered saline (PBS) containing 0.03% Tween (PBST) before
the antibodies (suspended in PBST) were added. Bound
antibodies were detected with anti-mouse or anti-rabbit
immunoglobulin G (IgG) peroxidase conjugates (Jackson
Immunoresearch Laboratories), and visualized by enhanced
chemiluminescence (SuperSignal Pico West, Pierce).Animal experiments
Animal experiments were conducted as described previously
(Osterrieder et al., 1996; von Einem et al., 2004). Briefly, 3- to
4-week-old female BALB/c mice (10 mice per group) were
infected with the various virus preparations by the intranasal
route at 105 PFU. Virus was suspended in 20 μl of DMEM–
10% FBS. Two mice were euthanized on days 3 and 5 p.i. The
left lobe of the extracted lung was homogenized and virus titers
in lungs were determined by standard titration on RK13 cells,
whereas the right lobe was fixed with a 10% formaldehyde
solution and processed for histopathological analysis. Also,
individual weights of mice were determined on the day of
infection (day 1) until day 13. Body weights were examined by
analysis of variance and multiple comparisons of the groups.
For dose response experiments various virus preparations
were applied to groups of ten mice by the intranasal route at 105,
104 and 103 PFU. On days 2 and 4 p.i., five mice of each group
were euthanized to remove the lung. After homogenization of
lung tissue, virus titers were determined by standard titration of
RK13 cells. Additionally, data of individual body weights were
collected throughout the time course of the experiment and
analyzed as described above. For histopathology, lungs from
mice infected with RacL11 and gG-negative virus at 1×103 and
1×104 PFU/animal, respectively, were harvested at day 4 p.i.
and processed for histopathological analysis exactly as
described previously (Smith et al., 2005).
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